FUJIFILM Holdings Corp · TSE:4901
FUJIFILM — Investor Presentation (February 2008)
4 slides from FUJIFILM's investor presentation, Feb 26, 2008
Slide 1: Product Pipeline of Toyama Chemical
Product Pipeline of Toyama Chemical February 26, 2008 FORWARD-LOOKING FORWARD-LOOKING STATEMENTS STATEMENTS Forward-looking Forward-looking statements statements such such as as those those relating relating toto earnings earnings forecasts forecasts and and other other projections projections conta
Slide 2: Current State of New Drug Development
Current State of New Drug Development Drug-discovery Non-clinical PI PII PIII Filed Approval platform/search study OZEX Fine granules for pediatric Anti-infective area Expand indications T-3811ME PASIL for Antibacterial agent (Injection) Geninax tablets Intravenous drip infusion (Oral) T-3912 YP-18
Slide 3: Outline of Drugs under Development
Outline of Drugs under Development Development Area of Characteristics number effectiveness Alzheimer’s In addition to inhibiting neural cell death, this drug helps T-817MA disease treatment promote neurite growth. It also shows potency in animal agent models of AD. By inhibiting the transcription f
Slide 4: Leading-edge technologies to enhance quality of life worldwide
We will use leading-edge, proprietary technologies to provide top-quality products and services that contribute to the advancement of culture, science, technology and industry, as well as improved health and environmental protection in society. Our overarching aim is to help enhance the quality of l
Fujifilm Holdings — Investor Presentation (February 2008) on 6ix